You are here: All Products  > BeiGene Pays $45 Million Upfront for Global Rights to Shoreline Cell Therapies

BeiGene Pays $45 Million Upfront for Global Rights to Shoreline Cell Therapies

Price: $5.00
Available

Get instant access to this article for unlimited viewing and/or downloading for seven days.


Back to products